Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma

Background: Lung adenocarcinoma (LUAD) possesses a poor prognosis with a low 5-year survival rate even for stages I-III resected patients, it is thus critical to understand the determinants that affect the survival and discover new potentially prognostic biomarkers. Somatic copy number alterations (...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiaohong, Tan, Qiaoyun, Yang, Sheng, Li, Junling, Xu, Jianping, Hao, Xuezhi, Hu, Xingsheng, Xing, Puyuan, Liu, Yutao, Lin, Lin, Gui, Lin, Qin, Yan, Yang, Jianliang, Liu, Peng, Wang, Xingyuan, Dai, Wumin, Lin, Dongmei, Lin, Hua, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691340/
https://www.ncbi.nlm.nih.gov/pubmed/31448219
http://dx.doi.org/10.3389/fonc.2019.00556

Ejemplares similares

Ejemplares similares